Arrhythmias
Drug Safety Update
March 2022: Amiodarone (Cordarone X): reminder of risks of treatment and need for patient monitoring and supervision
October 2011: Dronedarone (Multaq▼): cardiovascular, hepatic and pulmonary adverse events – new restrictions and monitoring requirements
NICE Guidance (also see drug-specific links below)
CG196: Atrial fibrillation: diagnosis & management, June 2021
Drug level monitoring of digoxin is recommended because it has a narrow therapeutic index and therefore should be used with caution in the elderly and in renal impairment. Therapeutic concentration results should be interpreted alongside clinical findings and serum potassium levels. Measurement of digoxin levels should be taken at least 6 hours post dose. MTW: see local Therapeutic Drug Monitoring Guidance.
Patients are at an increased risk of digoxin toxicity if hypokalaemia occurs.
Administration route: when changing from tablets to elixir, ONE 62.5micrograms tablet is approximately equivalent to 50micrograms(1mL) elixir.
Amiodarone requires careful monitoring. See BNF for cautions, side effects, interactions and monitoring.
Dronedarone is a derivative of amiodarone. It must be used second line to other anti-arrhythmic agents including amiodarone. See BNF for cautions, side effects, interactions and monitoring. There is a shared care guideline for prescribing, please see here.
Doses of digoxin tablets and liquid are not bioequivalent. Please exercise caution when switching between preparations.
| Pack |
|---|
| 28 tablet |
| 500 tablet |
| Pack |
|---|
| 28 tablet |
| 500 tablet |
| Pack |
|---|
| 28 tablet |
| 500 tablet |
| Pack |
|---|
| 60 ml |
| Pack |
|---|
| 5 ampoule |
| Pack |
|---|
| 28 tablet |
| 56 tablet |
| 100 tablet |
| Pack |
|---|
| 28 tablet |
| 30 tablet |
| 56 tablet |
| 100 tablet |
| Pack |
|---|
| 28 tablet |
| Pack |
|---|
| 28 tablet |
| 30 tablet |
| 60 tablet |
| Pack |
|---|
| 5 ampoule |
| Pack |
|---|
| 1 pre-filled disposable injection |
| Pack |
|---|
| 40 capsule |
| 84 capsule |
| 90 capsule |
| 120 capsule |
| Pack |
|---|
| 40 tablet |
| 56 tablet |
| 60 tablet |
| Pack |
|---|
| 60 tablet |
| Pack |
|---|
| 60 tablet |
| 100 tablet |
| Pack |
|---|
| 5 ampoule |
| Pack |
|---|
| 6 vial |
| Pack |
|---|
| 6 vial |
Cardiac catheter use only.
| Pack |
|---|
| 1 bag |
Used for provocation testing in the diagnosis of Brugada syndrome
| Pack |
|---|
| 5 ampoule |
MTW: Agreed at DTMMC that this can be used as an alternative to quinidine in the event of quinidine being unavailable. Cardiologist only.
| Pack |
|---|
| 20 capsule |
| 60 capsule |
| Pack |
|---|
| 10 ampoule |
| Pack |
|---|
| 1 pre-filled disposable injection |
| Pack |
|---|
| 1 bag |
| 15 bag |
| Pack |
|---|
| 1 bag |
| 15 bag |
| Pack |
|---|
| 10 ampoule |
| 20 ampoule |
| 100 ampoule |
| Pack |
|---|
| 1 pre-filled disposable injection |
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary






